Stintzing, S., Ivanova, B., Ricard, I., Jung, A., Kirchner, T., Tannapfel, A., . . . Reinacher-Schick, A. (2018). Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial. Front Oncol.
استشهاد بنمط شيكاغوStintzing, Sebastian, et al. "Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression As Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated MCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial." Front Oncol 2018.
MLA استشهادStintzing, Sebastian, et al. "Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression As Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated MCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial." Front Oncol 2018.